The Herald of Everett, Washington
HeraldNet on Facebook HeraldNet on Twitter HeraldNet RSS feeds HeraldNet Pinterest HeraldNet Google Plus HeraldNet Youtube
HeraldNet Newsletters  Newsletters: Sign up | Manage  Green editions icon Green editions

Calendar

Splash! Summer guide

Weekly business news
HeraldNet Newsletter Delivered to your inbox each week.
Published: Wednesday, February 15, 2012, 12:01 a.m.

Drugmaker Roche warns of counterfeit cancer drug in U.S.

Associated Press
WASHINGTON -- The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S.
Roche's Genentech unit says the fake products do not contain the key ingredient in Avastin, which is used to treat cancers of the colon, lung, kidney and brain.
Doctors who suspect they have received counterfeit drug should contact the Food and Drug Administration's criminal unit or Roche quality assurance department. The company said any patient taking Avastin who experiences side effects should contact their doctor immediately.
The company says the counterfeit products do not have Genentech printed on the packaging, which appears on all FDA-approved packages of the drug. Additionally, real Avastin contains a six-digit lot number with no letters. All the text on the product's packaging should be in English.
The company believes drugs labeled with the following lot numbers may be fake: B86017, B6011 and B6010.
Avastin is a widely-prescribed cancer therapy that works by choking off the blood supply that feeds tumors, the first drug of its kind approved by the FDA.
The injectable drug generates about $6 billion per year for the Swiss drugmaker Roche, and in 2010 it was the 14th best-selling drug in the U.S., according to data tracking firm IMS Health.
----------
On the Web:
http://www.gene.com/gene/news/press-releases/press_statements/ps_021412.html
www.fda.gov/OCI
Story tags » DiseasesMedicinesRecalls

Share your comments: Log in using your HeraldNet account or your Facebook, Twitter or Disqus profile. Comments that violate the rules are subject to removal. Please see our terms of use. Please note that you must verify your email address for your comments to appear.

You are logged in using your HeraldNet ID. Click here to update your profile. | Log out.

Our new comment system is not supported in IE 7. Please upgrade your browser here.

comments powered by Disqus
digital subscription promo

Subscribe now

Unlimited digital access starting at 99 cents, or included with any print subscription.

HeraldNet highlights

Bad behavior
Bad behavior: Start of crab season brings out the worst in some
Longer, farther
Longer, farther: Air New Zealand gets first stretched 787
From seed to store
From seed to store: Photo essay: Follow marijuana from the grower to the seller
Summer spirits
Summer spirits: Four refreshing drinks for hot days, suggested by local experts